CARsgen Therapeutics Statements
21
Data from CARsgen Therapeutics`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
CNY - Chinese yuan
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
28 Aug, 2024
Expected release date:
—
CARsgen Therapeutics Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
291.93
0
59.24
0
374.71
-12.8 %
0
-374.71
12.8 %
0
-29.765
0
—
0
-404.47
21.4 %
0
—
0
-404.47
21.6 %
0
-0.728
555.48
—
—
100
—
0
—
—
0
327.61
0
72.215
0
429.67
14.3 %
0
-429.67
-14.3 %
0
-84.942
0
—
0
-514.61
-36.7 %
0
1.295
0
-515.91
-37.1 %
0
-0.931
553.9
—
-100 %
100
—
0
—
—
0
299.64
0
57.355
0
375.97
0.1 %
0
-375.97
-7.5 %
0
-0.364
0
—
0
-376.34
-9.7 %
0
—
0
-376.34
-7.3 %
0
-0.685
549.36
25.813
—
100
—
0
25.813
—
100
303.61
1176.2
61.294
237.5
375.54
58 %
1454.8
-349.73
-47.1 %
-1354.8
6.794
26.3
—
0
-342.93
92.2 %
-1328.5
7.645
29.6
-350.58
92 %
-1358.1
-0.637
550.42
—
—
100
—
0
—
—
0
164.63
0
59.273
0
237.67
—
0
-237.67
—
0
-0.601
0
-4 155.57
0
-4 393.85
—
0
—
0
-4 393.85
—
0
-19.681
223.25